Conformis Actera™ Hip System Receives 510(k) Clearance from the U.S. Food and Drug Administration
September 13, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Sept. 13, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical technology company featuring personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in the H.C. Wainwright & Co. 24th Annual Global Investment Conference
August 29, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis Reports Second Quarter 2022 Financial Results
August 08, 2022 16:45 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis Announces New Agreement with Vizient for Personalized Orthopedic Implants
August 01, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc., (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced it...
Conformis, Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference
July 28, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release Second Quarter 2022 Financial Results on August 8, 2022
July 05, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it...
Conformis Highlights New Clinical Study Findings that Knee Shapes are Highly Individualized and are Not Determined by Identifiers, Including Gender, Body Type, or Ethnicity
May 24, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., May 24, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a leading medical device company that features personalized knee and hip replacement products, today announced...
Conformis, Inc. to Participate in the H.C. Wainwright Global Investment Conference
May 10, 2022 08:00 ET
|
Conformis, Inc.
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that...
Conformis Reports First Quarter 2022 Financial Results
May 04, 2022 07:00 ET
|
Conformis, Inc.
BILLERICA, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today...
Conformis, Inc. to Release First Quarter 2022 Financial Results on May 4, 2022
April 11, 2022 16:30 ET
|
Conformis, Inc.
BILLERICA, Mass., April 11, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS) announced today it will release its financial results for the first quarter ended March 31, 2022, before the...